Brown & Brown (BRO) Approves $19M in Performance Equity Grants for Executive Team
BROWN & BROWN, INC.
Subscribe to track BRO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Brown & Brown (BRO) Approves $19M in Performance Equity Grants for Executive Team
Company: BROWN & BROWN, INC. (BRO) Form: 8-K | Filed: 2026/03/04 Significance: Low
Insider: J. Powell Brown (CEO) & Executive Team Title: Chief Executive Officer | Relationship: Officer
Transaction: • Type: Grant (Performance Stock Awards) • Shares: Formula-based (Not specified) • Price: Formula-based • Value: $19,000,000 (Target Value)
Key Insight: The Compensation Committee approved a Long-Term Incentive Plan for 2026-2030, granting $19M in target equity value to four NEOs, vesting over 5 years based on Share Price and EPS targets.
Market Context: Routine executive compensation disclosure. Transaction value represents ~0.08% of market cap, indicating minimal immediate dilution risk.
Comprehensive Analysis
SEC Filing Analysis: BROWN & BROWN, INC. (BRO)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Company establishes 2026-2030 Long-Term Incentive Plan with $19M in target equity grants for top executives.
- Market Impact: Neutral; routine compensation disclosure with negligible dilution impact.
Company Information
| Field | Value |
|---|---|
| Company | BROWN & BROWN, INC. |
| Ticker Symbol | BRO |
| CIK | 0000079282 |
| Industry | Insurance Agents, Brokers & Services |
Insider Information
| Field | Value |
|---|---|
| Name | J. Powell Brown (CEO) & Executive Team |
| Title/Position | Chief Executive Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 8-K |
| Transaction Date | 2026-03-03 |
| Transaction Code | A (Grant) |
| Security Type | Performance Stock Awards/Units |
| Shares Involved | Formula-based (Not specified) |
| Total Value | $19,000,000 (Target) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $19,000,000 |
| % of Market Cap | 0.078% |
| Shares Transacted | ~261,000 (Estimated) |
| % of Shares Outstanding | ~0.078% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $24.45 billion, a $19 million equity grant package is standard for a company of this size.
- Dilution Impact: Assuming a share price of ~$72.77 (derived from market cap), the grants represent approximately 261,000 shares, or less than 0.1% of the 336M shares outstanding. Dilution is negligible.
- Transaction Significance: The transaction is significant for governance and alignment of executive interests but immaterial for immediate stock price mechanics.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a standard compensation disclosure. The performance conditions (Share Price CAGR and EPS growth) align executive pay with shareholder value creation over a 5-year period (2026-2030), which is generally viewed favorably by long-term investors but does not trigger short-term price action.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral. The 5-year vesting schedule and performance hurdles (up to 805% payout for max performance) suggest the board has aggressive growth targets.
Additional Context
Transaction Notes
- Structure: Grants are split between Performance Stock Awards (PSAs) and Performance Stock Units (PSUs). Vesting is tied to 50% Share Price CAGR and 50% EPS CAGR relative to S&P 500.
- Participants:
- J. Powell Brown (CEO): $10,000,000
- R. Andrew Watts (CFO): $5,000,000
- J. Scott Penny: $2,500,000
- Chris L. Walker: $1,500,000
- Timing: Grants effective March 3, 2026, covering the performance period through 2030.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
